Corgi Mangos ETF MN 深 沪
已收盘 10-02 16:00:00 美东时间
25.77
-0.240
-0.92%
华盛通- 最 高26.01
- 今 开26.01
- 成交量 84.42万股
- 最 低 25.74
- 昨 收 26.01
- 总市值 49.28万
- 52周最高 26.01
- 市盈率 静 21.66
- 换手率 4414.34%
- 52周最低 7.25
- 委 比 -77.68%
- 总股本 1.91万
- 历史最高 26.01
- 量 比 1.79
- 振 幅 1.04%
- 历史最低 0.99
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Search Minerals appoints Jonathan Beigle as CEO
Search Minerals (SHCMF) announced that its board of directors has appointed Jonathan Beigle as chief executive officer and as a director of the company, effective September 25, 2026. In connection wit...
09-23 19:58
Abacus 2026年第二季度财报：营收增长30%，GAAP净利润下降
Abacus 2026年第二季度营收7300万美元，同比增长30%；GAAP稀释EPS由0.18美元降至0.07美元，调整后EBITDA增至3990万美元，Life Solutions增长但扩张费用令利润承压。
08-06 21:32
Abacus 5300万美元押注Manning & Napier 长寿主题转向迎来首个真正考验
阿巴库斯斥资约5300万美元收购管理规模180亿美元的曼宁-纳皮耶的少数股权，并达成覆盖产品分销、获客转介绍、联合产品研发三大板块的战略合作联盟，同步以机构投资...
06-26 20:31
Abacus Unveils LifeARC AI Platform, Invests in Manning & Napier
Abacus Global Management ( ($ABX) ) has provided an update. On June 10, 2026, A...
06-10 21:19
Alnylam Eyes Faster Drug Discovery With AI Partnership Worth Up To $2 Billion
Alnylam stock rises after a $2 billion AI-driven RNAi drug discovery collaboration with Inceptive as analysts maintain bullish price targets.
06-04 23:52
Abacus Global Management And Manning & Napier Announce Entrance Into Strategic Alliance Agreement And Closing Of Abacus's Minority Equity Investment In Manning & Napier
Strategic Partnership Brings Longevity Data, Actuarial Expertise, and Expanded Investment Capabilities to Manning & Napier ClientsMinority equity investment of ~$53 million from Abacus in Manning & Napier
05-27 20:02
Abacus Global Management and Manning & Napier Enter into Strategic Alliance Agreement and Announce Closing of Minority Investment
Abacus Global Management and Manning & Napier have entered into a Strategic Alliance Agreement, with Abacus making a minority equity investment of approximately $53 million in Manning & Napier. The partnership aims to create value in three key areas: lead generation, product development, and joint client solutions. Abacus will leverage its proprietary longevity data and actuarial expertise, while Manning & Napier will provide investment solutions...
05-27 12:00
Manning & Napier Cuts Alphabet Inc. Class A Stake
Manning & Napier Advisors LLC, managed by Bill Manning, recently executed a...
05-03 11:01
Manning & Napier Advisors Boosts Meta Platforms Stake 81K
Manning & Napier Advisors LLC, managed by Bill Manning, recently executed a...
05-03 11:01
Neurocrine Buys Soleno To Tap High-Growth Rare Disease Market
Neurocrine (NBIX) to acquire Soleno Therapeutics (SLNO) for $2.9B to expand its rare disease portfolio. Get the deal details here.
04-06 20:13
